Japan's Shionogi to buy US drugmaker IntraBio for $2bn
MLex Summary: Shionogi, a publicly listed Japanese pharmaceutical company, said Monday that it will acquire all shares in US pharmaceutical company IntraBio for $2 billion, adding rare-disease drug Aqneursa and its...To view the full article, register now.
Already a subscriber? Click here to view full article